000 | 01181 a2200349 4500 | ||
---|---|---|---|
005 | 20250515002514.0 | ||
264 | 0 | _c20060206 | |
008 | 200602s 0 0 eng d | ||
022 | _a0307-6938 | ||
024 | 7 |
_a10.1111/j.1365-2230.2005.01882.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeramiquel, L | |
245 | 0 | 0 |
_aOnset of flexural psoriasis during infliximab treatment for Crohn's disease. _h[electronic resource] |
260 |
_bClinical and experimental dermatology _cNov 2005 |
||
300 |
_a713-4 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
650 | 0 | 4 |
_aCrohn Disease _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGastrointestinal Agents _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfliximab |
650 | 0 | 4 |
_aPsoriasis _xchemically induced |
700 | 1 | _aPuig, L | |
700 | 1 | _aDalmau, J | |
700 | 1 | _aRicart, E | |
700 | 1 | _aRoe, E | |
700 | 1 | _aAlomar, A | |
773 | 0 |
_tClinical and experimental dermatology _gvol. 30 _gno. 6 _gp. 713-4 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2230.2005.01882.x _zAvailable from publisher's website |
999 |
_c15827793 _d15827793 |